National Cancer InstituteU.S. National Institutes of
Center to Reduce Cancer Health Disparities logo

Project Investigator Biography

William G. Nelson, M.D., Ph.D. William G. Nelson, M.D., Ph.D.

John Hopkins University
Dept. of Oncology
1650 Orleans Street, Rm. 151,
Cancer Research Building
Baltimore, MD 21231
phone: (410) 614-3252
fax: (410) 614-3695

Dr. William G. Nelson is a Professor of Oncology, Urology, Pharmacology, Medicine, Pathology, and Radiation Oncology at the Johns Hopkins University School of Medicine, with a Joint Appointment in Environmental Health Sciences at the Johns Hopkins University Bloomberg School of Public Health. Dr. Nelson serves as the Marion I. Knott Professor and Chairman of Oncology and the Director of the Sidney Kimmel Comprehensive Cancer Center.

For more than a decade, Dr. Nelson has directed a research laboratory focused on discovering new strategies for prostate cancer treatment and prevention, and manages a clinical practice focused on developing these new treatment and prevention approaches in early “proof-of-principle” prostate clinical trials. He is the Principal Investigator for the National Cancer Institute (NCI)-funded Molecular Targets Training Program, dedicated to providing clinical oncology fellows specific training in translational research, and for the NCI-supported Prostate Cancer SPORE Program, a multidisciplinary research effort for translational research targeting new approaches to prostate cancer detection, diagnosis, prevention, and treatment. Dr. Nelson further acts in a leadership role for the NCI-funded Howard University Cancer Center-Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer research programs at Johns Hopkins.

Outside of Johns Hopkins, Dr. Nelson has also become a recognized leader in translational cancer research and in cancer prevention research. He was one of three Co-Chairs of the National Cancer-Institute Translational Research Working Group, which reported its findings to the National Cancer Advisory Board in June of 2007. A member of the American Association for Cancer Research (AACR), he has served as a member of the Board of Directors, the Clinical Research Committee, the Public Education Committee, the Special Conferences Committee, the Science Policy and Legislative Affairs Committee (Chair from 2001-8), as well as several cancer prevention working groups and task forces.

View Partnership Abstract Description

Other Project Investigator
Duane T. Smoot, M.D., FACP, FACG
Updated: 04/30/12